| Identification | Back Directory | [Name]
Dibenzo[a,g]quinolizinium, 5,6-dihydro-3-hydroxy-2,9,10-trimethoxy-, hydroxide (9CI) | [CAS]
483-43-2 | [Synonyms]
Jatrorrhizine Hydroxide
Dibenzo[a,g]quinolizinium, 5,6-dihydro-3-hydroxy-2,9,10-trimethoxy-, hydroxide (9CI) | [Molecular Formula]
C20H20NO4.HO | [MDL Number]
MFCD32858327 | [MOL File]
483-43-2.mol | [Molecular Weight]
355.384 |
| Chemical Properties | Back Directory | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly), Water (Very Slightly) | [form ]
Solid | [color ]
Very Dark Red to Black | [Water Solubility ]
Water: 5 mg/mL (14.07 mM) | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
Jatrorrhizine Hydroxide is hydroxide salt of Jaztorrhizine, which is an alkaloid extract from the Berberidaceae family of plants displaying antioxidant activity. | [in vivo]
Jatrorrhizine (intraperitoneal?injection; 5, 10, 20 mg/kg) can significantly reduce the duration of immobility when compared with vehicle control group in tail suspension test (TST)[2]. | Animal Model: | Male ICR albino mice[2] | | Dosage: | 5, 10, 20 mg/kg | | Administration: | Intraperitoneal?injection; 5, 10, 20 mg/kg | | Result: | Reduced immobility period in tail suspension test. |
| [IC 50]
AChE | [storage]
4°C, protect from light |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|